AGL.L

ANGLE plc

1AGL
GBR
LSE

$0.23

24H

0.9%

Market Cap

608.5 K

Volume

273.4 K

Supply

2.6 M

Price Chart

About ANGLE plc - AGL.L

ANGLE plc is a publicly traded company that specializes in the development of cancer diagnostics, particularly focusing on products that can capture and analyze circulating tumor cells from blood samples. Their flagship product, the Parsortix system, allows for the capture and harvest of rare cells for analysis, which can aid in personalized cancer care and ongoing treatment decisions.

What are ANGLE plc's core values and mission statement?

ANGLE plc's mission is to improve cancer care and patient outcomes by delivering clinically actionable information from live circulating tumor cells (CTCs). The company values pioneering research and development, clinical rigor, and partnerships to advance diagnostics in oncology and fetal health.

Who founded ANGLE plc and when?

ANGLE plc was founded by Andrew Newland in 1994.

Who leads ANGLE plc?

As of the last update prior to the cutoff, ANGLE plc was led by founder and CEO Andrew Newland.

Where is ANGLE plc located, and what is its base country?

ANGLE plc is based in the United Kingdom.

On which exchanges is ANGLE plc traded?

ANGLE plc is listed and traded on the London Stock Exchange.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

ANGLE plc (AGL) Price Live Data

The live price of ANGLE plc (AGL) is $0.23, with a trading volume of 273,359 in the last 24 hours. Wrapstocks updates the AGL price in real-time. ANGLE plc is down -0.9% in the last 24 hours. The company has a live market cap of $608,451.21 and a supply of 2,605,810 AGL stocks.

ANGLE plc (AGL) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 8 hours and 6 minutes.

Exchange
LSE
LSE
London Stock Exchange
GBR
Opens in
8 hours and 6 minutes
Working Hours
Mon-Fri, 07:00 AM - 11:00 AM / 01:02 PM - 03:30 PM
Timezone
GMT+0
Last Updated
24 May 2024 02:56 PM